Transcriptomic profiling predicting response to ustekinumab therapy in patients with Crohn's disease

ABSTRACT: This study aimed to identify a biomarker predicting response to ustekinumab therapy. Therefore, we used transcriptomic data (colonic and ileal tissue, CD4 T-cell and CD14 monocytes), which we integrated through Multi-Omics Factor Analysis.

INSTRUMENT(S): Illumina HiSeq 4000

ORGANISM(S): Homo sapiens

SUBMITTER: Bram Verstockt 

PROVIDER: E-MTAB-7799 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress